NORD: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Medical Assistance)
Not Funded
About
The NORD: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Medical Assistance program offers substantial support for individuals diagnosed with CIDP. With a focus on providing access to critical drug products such as Gammagard Liquid, Gamunex-C, Hizentra, and others, this program ensures eligible patients receive necessary medical assistance. The program facilitates both online and phone applications, offering a seamless enrollment process with potential same-day approval.
Insurance requirements: Underinsured, Uninsured
Enrollment Forms
Enrollment Form
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: Yes
•Activation Required: No
Program Details
•Please note the following:
•1. Specific drug coverage is not indicated on program website; drug coverage must be verified by calling program
•2. Specialty Pharmacy representatives/case managers can send new referrals through the referral portal (https://rareaccess.org/#/login). Representatives must be preregistered by sending a request to RareAccess@rarediseases.org. Representatives can also email the program email address. To make the problem resolution quicker and more efficient please do not send messages to individual emails. If the matter is URGENT, please reach out to SP account manager for NORD to escalate the issue
•Patients may apply online, call (2032679005) or email (CIDP@rarediseases.org) program to enroll
•Awards are made for a calendar year, and patients may reapply for subsequent years
•NORD is able to offer same day approval for programs
•Patients must undergo a financial evaluation of need, and provide HIPPA authorization and accept a waiver of liability
•Fax number for program is 2032661002
Enrollment Forms
Enrollment Form
Other Programs
Accessia Health: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Private Insurance
HyQvia at no costSee program details for eligibility
Assistance Fund: Activated Phosphoinositide 3-kinase Delta Syndrome (APDS)
HyQvia at no costSee program details for eligibility